Q3 EPS Forecast for Walgreens Boots Alliance Cut by Analyst

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Stock analysts at Leerink Partnrs cut their Q3 2025 earnings estimates for shares of Walgreens Boots Alliance in a research note issued to investors on Tuesday, October 15th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will earn $0.33 per share for the quarter, down from their prior forecast of $0.39. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $2.85 per share. Leerink Partnrs also issued estimates for Walgreens Boots Alliance’s Q4 2025 earnings at $0.33 EPS.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same quarter in the prior year, the firm earned $0.67 EPS. The business’s revenue for the quarter was up 5.9% compared to the same quarter last year.

Several other research firms have also commented on WBA. UBS Group increased their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. TD Cowen dropped their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Royal Bank of Canada dropped their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Finally, Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $13.38.

Walgreens Boots Alliance Price Performance

WBA stock opened at $10.79 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. Walgreens Boots Alliance has a 52 week low of $8.22 and a 52 week high of $27.05. The firm’s fifty day moving average is $9.41 and its 200 day moving average is $13.14. The firm has a market cap of $9.31 billion, a P/E ratio of -1.60, a P/E/G ratio of 1.06 and a beta of 0.70.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Capital World Investors increased its stake in Walgreens Boots Alliance by 57.5% during the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after purchasing an additional 10,612,373 shares in the last quarter. Thompson Siegel & Walmsley LLC increased its stake in Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after purchasing an additional 2,992,648 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its stake in Walgreens Boots Alliance by 6.1% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock valued at $32,882,000 after purchasing an additional 156,484 shares in the last quarter. Newport Trust Company LLC bought a new stake in Walgreens Boots Alliance during the 2nd quarter valued at about $31,028,000. Finally, Ariel Investments LLC increased its stake in Walgreens Boots Alliance by 10.8% during the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock valued at $24,660,000 after purchasing an additional 198,891 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.